Purchase Order 75N90023P00765

Award Date 8/31/23
Potential Completion Date 9/30/23
Potential Value $14K
Federal Agency
NIH Clinical Center
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $79,213.50 firm fixed-price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract is for the delivery of 24-007875 DG32 automated droplet generator cartridges, which are consumables used with the QX600/QX200 AutoDG Droplet Digital PCR System. This equipment is utilized in biomedical...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,498.48 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for DG32 automated droplet generator cartridges. Bio-Rad Laboratories, Inc. will deliver the requested cartridges to the NIH Clinical Center location in Bethesda, Maryland by September 30, 2023 to support the center's research and care activities. No subcontractors or set aside designations were...
This $22,507.81 firm fixed-price purchase order contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The contract is for a QX200 Droplet Digital PCR System to support the agency's biomedical research programs. No set-aside designation was used for this award. Bio-Rad Laboratories is an experienced...
This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Bio-Rad Laboratories, Inc. Life Science Group Division. The contract, valued at $144,763.50, is for the provision of a Bio-Rad QX200 Droplet Digital PCR system and associated products and services. The contract is not set aside for any special category of business. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing a wide range of...
This contract award from the National Institutes of Health (NIH) to Bio-Rad Laboratories, Inc. Life Science Group Division is for the purchase of a variety of products and services related to biomedical research and testing, including real-time PCR systems, thermal cyclers, gel imaging systems, digital droplet PCR instruments, multiplex assays, reagent kits, and associated maintenance and support services. The award, valued at $4,923.90, is a firm fixed price purchase order with no set-aside...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,671 purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a service agreement for digital PCR instruments. As the prime contractor, Bio-Rad will provide services and support for digital PCR instruments located at the National Cancer Institute in Rockville, Maryland over a one year period from November 2023 through November 2024. The contract is a firm fixed...
The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $18,829.73 firm-fixed-price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a digital PCR system with an auto-loading feature and a one-year full on-site support plan. The contract, which has a completion date of July 31, 2021, was not set aside for any specific business category. Bio-Rad Laboratories, Inc. is a leading manufacturer of...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The $14,376.05 contract is for the provision of custom digital droplet PCR (ddPCR) gene expression assays. No set-aside designation was used. Bio-Rad Laboratories, Inc. is an experienced federal contractor, holding...
This federal contract award, valued at $24,630.75, was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. Life Science Group Division. The contract is for the procurement of consumables, specifically for a QX200 droplet digital polymerase chain reaction (ddPCR) machine, to support ongoing experiments at the NHLBI's Laboratory of Applied Precision Omics. This purchase order contract has a firm...
The National Institutes of Health's National Institute of Environmental Health Sciences awarded a $12,509 purchase order to Bio-Rad Laboratories, Inc. for DDPCR gene expression. Bio-Rad will deliver the requested products and services under a firm fixed price contract over a one-month period of performance ending in October 2023. As a leading life sciences research tools and clinical diagnostics company, Bio-Rad will leverage its expertise and infrastructure to support NIEHS's environmental...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order valued at fourteen thousand four hundred fifty-five dollars and twenty cents ($14,455.20) to Bio-Rad Laboratories, Inc. Life Science Group Division for QX600/QX200 AUTODG DROPLET DIGITAL PCR SYSTEMs. As the prime contractor, Bio-Rad Laboratories will provide the requested products to the NIH Clinical Center in Bethesda, Maryland between August 31, 2023 and September 30, 2023. No major subcontractors or set aside designations were indicated. This appears to be a small purchase to support the NIH Clinical Center's biomedical research efforts through the acquisition of droplet digital PCR technology.

Generated 12/22/23, 9:44 PM